Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Growth in infants receiving modified fat breast milk for the treatment of chylothorax following cardiothoracic surgery

EF 2014-15

Résumé
Breast milk is the gold standard for infant feeding. It is recommended to be the sole source of nutrition for the first 6 months of life with continued provision to one year. When an infant is diagnosed with chylothorax, a complication that can occur after cardiac surgery, breast milk must be stopped temporarily due to the type of fat naturally present in breast milk. The infant is switched to a specialized treatment formula high in medium chain triglycerides (MCT) for a minimum of 6 weeks. At the Hospital for Sick Children (SickKids) there is great interest from families and health care providers to use breast milk, in a modified fat form, for the treatment of chylothorax. The use of modified fat breast milk (MFBM) was studied in infants with chylothorax at SickKids previously and although it was successful in treating chylothorax, infants receiving the MFBM did not grow as well as compared to infants on the specialized MCT formula. Therefore, further research on the use of MFBM and its' impact on growth is required before widespread clinical adoption at SickKids. Although MFBM has been studied at other centres, none have reported on the growth outcomes of the infants. The goal of this study is to develop an ideal feeding strategy using MFBM to support optimal growth in infants with chylothorax. Two different methods of MFBM fortification/nutrient enrichment will be tested. If either of them reduce or eliminate the growth issues previously observed, MFBM will become a standard treatment option for infants with chylothorax at SickKids.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
331278
Name
DiLauro Sara
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Growth in infants receiving modified fat breast milk for the treatment of chylothorax following cardiothoracic surgery
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cardiothoracic Surgery; Chylothorax; Dietary Fats; Growth; Human Milk; Infants; Modified Fat Breast Milk; Nutrition; Target Fortification
Abstract
Breast milk is the gold standard for infant feeding. It is recommended to be the sole source of nutrition for the first 6 months of life with continued provision to one year. When an infant is diagnosed with chylothorax, a complication that can occur after cardiac surgery, breast milk must be stopped temporarily due to the type of fat naturally present in breast milk. The infant is switched to a specialized treatment formula high in medium chain triglycerides (MCT) for a minimum of 6 weeks. At the Hospital for Sick Children (SickKids) there is great interest from families and health care providers to use breast milk, in a modified fat form, for the treatment of chylothorax. The use of modified fat breast milk (MFBM) was studied in infants with chylothorax at SickKids previously and although it was successful in treating chylothorax, infants receiving the MFBM did not grow as well as compared to infants on the specialized MCT formula. Therefore, further research on the use of MFBM and its' impact on growth is required before widespread clinical adoption at SickKids. Although MFBM has been studied at other centres, none have reported on the growth outcomes of the infants. The goal of this study is to develop an ideal feeding strategy using MFBM to support optimal growth in infants with chylothorax. Two different methods of MFBM fortification/nutrient enrichment will be tested. If either of them reduce or eliminate the growth issues previously observed, MFBM will become a standard treatment option for infants with chylothorax at SickKids.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
DiLauro, Sara
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~